Galmed Pharmaceuticals GLMD
NASDAQ GLMD
$4.56 -0.21 (-4.46%)
At close: Aug 20, 2026 · 4:00 PM EDT

Galmed Pharmaceuticals (GLMD) Debt Ratio (2013 - 2026)

Galmed Pharmaceuticals (GLMD) posted quarterly Debt Ratio of 0.02 for Q1 2026, down 17.06% year-over-year from 0.03 in Q1 2025, and down 51.0% quarter-over-quarter from 0.05 in Q4 2025.

Galmed Pharmaceuticals (GLMD) Debt Ratio (2013 - 2026) Analysis & Trends

Galmed Pharmaceuticals' Debt Ratio history runs 14 years deep, the most recent figure standing at 0.02 for Q1 2026.

  • In Q1 2026, Debt Ratio fell 17.06% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (down 17.06% YoY), while the FY2025 annual figure was 0.05, down 91.57% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.02, down from 0.05 in the prior quarter.
  • The five-year high for Debt Ratio was 0.54 in Q4 2024, with the low at 0.02 in Q1 2026.
  • The 5-year median for Debt Ratio is 0.04 (2023), against an average of 0.09.
  • The sharpest annual moves came in 2023 and 2024: Debt Ratio jumped 1566.26% in 2023, then plunged 94.13% in 2024.
  • Galmed Pharmaceuticals' Debt Ratio stood at 0.03 in 2022, then surged by 62.44% to 0.05 in 2023, then soared by 923.73% to 0.54 in 2024, then slumped by 91.57% to 0.05 in 2025, then slumped by 51.0% to 0.02 in 2026.
  • Business Quant data shows GLMD's Debt Ratio at 0.02 in Q1 2026, 0.05 in Q4 2025, and 0.04 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.05
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.26
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.47
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.03
10 Galmed Pharmaceuticals 2.39 Mn -9.49 Mn - 0.02

Historic Data

Download Data
DateValue
Mar 31, 2026 0.02
Dec 31, 2025 0.05
Sep 30, 2025 0.04
Jun 30, 2025 0.05
Mar 31, 2025 0.03
Dec 31, 2024 0.54
Sep 30, 2024 0.06
Jun 30, 2024 0.03
Mar 31, 2024 0.03
Dec 31, 2023 0.05
Sep 30, 2023 0.03
Jun 30, 2023 0.04
Mar 31, 2023 0.45
Dec 31, 2022 0.03
Jun 30, 2022 0.03
Mar 31, 2022 0.03
Dec 31, 2021 0.03
Sep 30, 2021 0.03
Jun 30, 2021 0.03
Mar 31, 2021 0.02